22 January 2019 08:30 CET

Karo Intressenter AB fullföljer erbjudandet till aktieägarna i Karo Pharma Aktiebolag och förlänger acceptfristen

#EQT VIII #Karo Pharma

För mer information, klicka här.

Latest news

09 December 2022
EQT Future and ATHOS, alongside other co-investors, invest in SHL Medical, a world-leading provider of advanced drug delivery solutions
01 December 2022
EQT partners with Nobel Prize Outreach to inspire and engage global audiences on societal challenges
28 November 2022
EQT Infrastructure enters exclusive negotiations to acquire a majority stake in Trescal, a global leader in calibration laboratories
22 November 2022
EQT AB’s Nomination Committee for the Annual Shareholders’ Meeting 2023
22 November 2022
Karo Intressenter AB announces final outcome of the public cash offer to the shareholders in Karo Pharma Aktiebolag